Taiwania Capital
Po-Ting Hsieh is currently working as an Investment Manager at 台杉投資. Prior to this, they held roles at United Biopharma and Medigen Vaccine Biologics Corp, focusing on business development, marketing, and project management in the biotech industry. Po-Ting also has a background in biomedical science with degrees from Chang Gung University.
This person is not in any offices
Taiwania Capital
1 followers
Taiwania Capital is a venture capital firm founded in August 2017 by the National Development Fund of the Executive Yuan of Taiwan and private enterprises. Our mission is to establish a partnership with companies worldwide and boost Taiwan’s economic growth. Taiwania Capital is a venture capital that focuses on investing in technologies and biotech areas start-ups that are Taiwan or US-based with disruptive and advanced technology. Taiwania Capital is named after Taiwania cryptomerioides, a unique tree species that took its name from Taiwan in 1906. With heights reaching up to 90 meters, the Taiwania tree is one of the tallest tree species in Asia, and surrounding it is a diverse and vibrant ecosystem. By linking technology and capital, Taiwania Capital aspires to also create a robust ecosystem in Taiwan that is rooted in entrepreneurial innovation.